End Cash: The amount of cash held by the company for the given period.
Entrada Therapeutics, Inc. (TRDA) had End Cash of $97.24M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$1.61M |
|
$-44.13M |
|
-- |
|
$1.61M |
|
$48.66M |
|
$-47.05M |
|
$3.57M |
|
$-43.48M |
|
$-43.48M |
|
$-44.13M |
|
$-44.13M |
|
$-44.13M |
|
$-44.13M |
|
$-47.05M |
|
$-46.56M |
|
41.46M |
|
41.46M |
|
$-1.06 |
|
$-1.06 |
|
| Balance Sheet Financials | |
$338.26M |
|
$8.41M |
|
$74.64M |
|
$412.90M |
|
$24.02M |
|
-- |
|
$48.16M |
|
$72.18M |
|
$340.72M |
|
$340.72M |
|
$340.72M |
|
38.22M |
|
| Cash Flow Statement Financials | |
$-96.31M |
|
$87.69M |
|
$0.69M |
|
$105.16M |
|
|
End Cash |
$97.24M |
$-7.92M |
|
$15.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.08 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-2915.18% |
|
-2915.18% |
|
-- |
|
-2693.93% |
|
-2734.45% |
|
$-97.56M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
1.35 |
|
66.69 |
|
-12.95% |
|
-12.95% |
|
-10.69% |
|
-12.95% |
|
$8.91 |
|
$-2.35 |
|
$-2.32 |
|